NO944531D0 - Diaminsalter av clavulansyre - Google Patents

Diaminsalter av clavulansyre

Info

Publication number
NO944531D0
NO944531D0 NO944531A NO944531A NO944531D0 NO 944531 D0 NO944531 D0 NO 944531D0 NO 944531 A NO944531 A NO 944531A NO 944531 A NO944531 A NO 944531A NO 944531 D0 NO944531 D0 NO 944531D0
Authority
NO
Norway
Prior art keywords
clavulanic acid
diamine salts
salts
diamine
new
Prior art date
Application number
NO944531A
Other languages
English (en)
Other versions
NO301767B1 (no
NO944531L (no
Inventor
Pieter Gijsbert Weber
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of NO944531D0 publication Critical patent/NO944531D0/no
Publication of NO944531L publication Critical patent/NO944531L/no
Publication of NO301767B1 publication Critical patent/NO301767B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrrole Compounds (AREA)
NO944531A 1993-03-26 1994-11-25 Salt av clavulansyre NO301767B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93200872 1993-03-26
PCT/EP1994/000919 WO1994022873A1 (en) 1993-03-26 1994-03-22 Diamine salts of clavulanic acid
US08/457,985 US5719277A (en) 1993-03-26 1995-06-01 Diamine salts of clavulanic acid

Publications (3)

Publication Number Publication Date
NO944531D0 true NO944531D0 (no) 1994-11-25
NO944531L NO944531L (no) 1994-11-25
NO301767B1 NO301767B1 (no) 1997-12-08

Family

ID=26133724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944531A NO301767B1 (no) 1993-03-26 1994-11-25 Salt av clavulansyre

Country Status (22)

Country Link
US (1) US5719277A (no)
EP (2) EP0719778A1 (no)
CN (1) CN1041933C (no)
AT (1) ATE140703T1 (no)
AU (1) AU682030B2 (no)
CA (1) CA2135671A1 (no)
CY (1) CY1966A (no)
CZ (1) CZ284855B6 (no)
DE (2) DE69400334T2 (no)
DK (1) DK0647229T3 (no)
ES (1) ES2070109T3 (no)
FI (1) FI945510A (no)
HK (1) HK217196A (no)
HU (1) HUT69372A (no)
IL (1) IL109139A (no)
NO (1) NO301767B1 (no)
NZ (1) NZ263564A (no)
PL (1) PL306371A1 (no)
RO (1) RO112113B1 (no)
SK (1) SK279918B6 (no)
WO (1) WO1994022873A1 (no)
ZA (1) ZA942133B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
AU678752B3 (en) * 1992-06-11 1997-06-05 Smithkline Beecham Plc Process for the preparation of clavulanic acid
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
GB2282810B (en) * 1992-06-11 1997-02-26 Smithkline Beecham Plc Preparation or purification of clavulanic acid
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9426261D0 (en) 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
PL321871A1 (en) * 1995-02-25 1997-12-22 Spurcourt Ltd Clavulanic salts and compositions containing them as well as method of obtaining such salts
SI9500134B (sl) * 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
SI9500265A1 (en) 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
US6071532A (en) * 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
EP1095046A1 (en) * 1998-07-16 2001-05-02 Dsm N.V. Improved process for the preparation of salts and esters of clavulanic acid
US6908663B1 (en) * 2000-11-15 2005-06-21 Awi Licensing Company Pigmented radiation cured wear layer
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
DE3063683D1 (en) * 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
GB9305565D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes

Also Published As

Publication number Publication date
ES2070109T1 (es) 1995-06-01
FI945510A0 (fi) 1994-11-23
DE69400334T2 (de) 1997-02-13
ZA942133B (en) 1995-02-21
DE647229T1 (de) 1996-01-18
FI945510A (fi) 1994-11-23
DK0647229T3 (da) 1996-10-07
PL306371A1 (en) 1995-03-20
CZ286394A3 (en) 1995-03-15
RO112113B1 (ro) 1997-05-30
WO1994022873A1 (en) 1994-10-13
EP0647229B1 (en) 1996-07-24
SK279918B6 (sk) 1999-05-07
SK144294A3 (en) 1995-06-07
CN1108029A (zh) 1995-09-06
HUT69372A (en) 1995-09-28
CZ284855B6 (cs) 1999-03-17
NO301767B1 (no) 1997-12-08
AU6429494A (en) 1994-10-24
DE69400334D1 (de) 1996-08-29
HK217196A (en) 1996-12-27
HU9403383D0 (en) 1995-02-28
CY1966A (en) 1997-07-04
US5719277A (en) 1998-02-17
IL109139A0 (en) 1994-06-24
ES2070109T3 (es) 1996-12-01
CA2135671A1 (en) 1994-10-13
IL109139A (en) 1997-03-18
AU682030B2 (en) 1997-09-18
NO944531L (no) 1994-11-25
CN1041933C (zh) 1999-02-03
NZ263564A (en) 1995-12-21
EP0719778A1 (en) 1996-07-03
ATE140703T1 (de) 1996-08-15
EP0647229A1 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
DK0490823T3 (no)
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
AU642913B2 (en) New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and the manufacture and use of said compounds
CA2166483A1 (en) New Pharmaceutical Formulation
ATA256092A (de) Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE121295T1 (de) Augentropfenarzneimittel.
NO944531D0 (no) Diaminsalter av clavulansyre
DE68909412T2 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
NO174032C (no) Fremgangsmåte for fremstilling av en legemiddel-polymer-matriks innbefattende dimenhydrinat som en aktiv bestanddel
SE9300758L (sv) Förfarande för framställning av kavulansyrasalter
GR3025951T3 (en) Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
NO920313D0 (no) Fremgangsmaate for fremstilling av rasemisk og optisk aktiv 1,2,3,4-tetrahydroisokinolin-3-karbonsyre samt forprodukter derav
AU8379091A (en) New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
AU6367690A (en) Optically active thiazetoquinoline-3-carboxylic acid compound, method for preparation thereof, and a pharmaceutical composition comprising the same
CA2101548A1 (en) Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
ATE58530T1 (de) 1,4-dihydropyridinverbindungen und ihre herstellung und pharmazeutische formulierung.
DE3675747D1 (de) 1,4-dihydropyridinverbindungen und ihre herstellung und pharmazeutische formulierung.
GB9105580D0 (en) New amino acid derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same
ZA917229B (en) New amino acid derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same
DE3766377D1 (de) N-alkyl-nortropine ester und ihre quaternaeren derivate mit anti-bronchospastischer wirkung, verfahren zu deren herstellung und diese enthaltende arzneimittel.